A. Setiawansyah, “Aaptamine Enhanced Doxorubicin Activity on B-Cell Lymphoma 2 (Bcl-2): A Multi-Structural Molecular Docking Study”, ad-dawaa.j.pharm.sci, vol. 7, no. 1, pp. 1-10, Jun. 2024.